The Use of Precision Medicine to Support the Precision of Clinical Decisions in care delivery

Summary

Objectives: Objective: Precision medicine uses individualized patient data, including genomic and social determinants of health SDoH), to provide optimized personalized patient treatment. In this scoping review, we summarize studies published in the last two years that reported on implementation of precision medicine in clinical decision support (CDS) related to precision medicine.

Methods: We searched PubMed for manuscripts published in 2022 and 2023 to retrieve publications that included CDS and precision medicine keywords and Mesh terms. We reviewed the abstracts and full texts to apply the inclusion criteria that the study must have described the implementation of precision medicine related CDS within electronic health records. We extracted the domain, type of data used in CDS, target population included in the implementation from the final set of included manuscripts.

Results: Our search retrieved 285 manuscripts and papers. Sixteen (16) papers met inclusion criteria after manual review of the full text. Eight of the reviewed papers studied the successful implementation of pharmacogenomics in CDS, four studies investigated the implementation of disease risk, and only one paper described the implementation of CDS integrating social determinants of health.

Conclusion: Our scoping review of recent literature highlighted several findings. Pharmacogenomics is the most implemented precision medicine intervention based on published studies. Few reports describing disease risk and polygenic risk scores were found and no study addressed CDS for continuous biometric monitoring. Despite the increasing attention to social determinants of health as a key predictor of health outcomes, only one CDS incorporating SDoH have been publicly reported. Regular updates to scoping reviews can investigate barriers to implementation and identify solutions.

Keywords

Precision medicine - clinical decision support - pharmacogenomics - social determinants of health - disease risk - genomics

Publikationsverlauf

Artikel online veröffentlicht:
08. April 2025

• References

• 1 Turnbull C, Firth H V, Wilkie AOM, Newman W, Raymond FL, Tomlinson I, et al. Population screening requires robust evidence—genomics is no exception. The Lancet [Internet]. 2023; Available from: https://www.sciencedirect.com/science/article/pii/S014067362302295X
• 2 Meaddough EL, Sarasua SM, Fasolino TK, Farrell CL. The impact of pharmacogenetic testing in patients exposed to polypharmacy: a scoping review. Vol. 21, Pharmacogenomics Journal. 2021.
• 3 Ratnani I, Fatima S, Abid MM, Surani Z, Surani S. Evidence-Based Medicine: History, Review, Criticisms, and Pitfalls. Cureus. 2023.
• 4 Sirajuddin AM, Osheroff JA, Sittig DF, Chuo J, Velasco F, Collins DA. Implementation pearls from a new guidebook on improving medication use and outcomes with clinical decision support. J Healthc Inf Manag. 2009;23(4).
• 5 Campbell R. The five ‘rights’ of clinical decision support cds tools helpful for meeting meaningful use. Journal of the American Health Information Management Association. 2013;84(10).
• 6 Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI. An overview of clinical decision support systems: benefits, risks, and strategies for success. Vol. 3, npj Digital Medicine. 2020.
• 7 Kubben P, Dumontier M, Dekker A. Fundamentals of clinical data science. Fundamentals of Clinical Data Science. 2018.
• 8 Peterson JF, Field JR, Shi Y, Schildcrout JS, Denny JC, McGregor TL, et al. Attitudes of clinicians following large-scale pharmacogenomics implementation. Pharmacogenomics Journal. 2016;16(4).
• 9 Peterson JF, Bowton E, Field JR, Beller M, Mitchell J, Schildcrout J, et al. Electronic health record design and implementation for pharmacogenomics: A local perspective. Genetics in Medicine. 2013;15(10).
• 10 Pulley JM, Denny JC, Peterson JF, Bernard GR, Vnencak-Jones CL, Ramirez AH, et al. Operational Implementation of Prospective Genotyping for Personalized Medicine: The Design of the Vanderbilt PREDICT Project. Clin Pharmacol Ther [Internet]. 2012 Jul 16 (cited 2017 Nov 27);92(1):87–95. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22588608
• 11 Baccarelli A, Dolinoy DC, Walker CL. A precision environmental health approach to prevention of human disease. Nat Commun. 2023;14(1).
• 12 Kwon IWG, Kim SH, Martin D. Integrating social determinants of health to precision medicine through digital transformation: An exploratory roadmap. Int J Environ Res Public Health. 2021;18(9).
• 13 Chase DA, Baron S, Ash JS. Clinical decision support and primary care acceptance of genomic medicine. In: Studies in Health Technology and Informatics. 2017.
• 14 Smith DM, Wake DT, Dunnenberger HM. Pharmacogenomic Clinical Decision Support: A Scoping Review. Vol. 113, Clinical Pharmacology and Therapeutics. 2023.
• 15 Johnson D, Fiol G Del, Kawamoto K, Romagnoli K, Sanders N, Isaacson G, et al. Genetically Guided Precision Medicine Clinical Decision Support Tools: A Systematic Review. medRxiv [Internet]. 2023 Jan 1;2023.08.23.23294506. Available from: http://medrxiv.org/content/early/2023/08/24/2023.08.23.23294506.abstract
• 16 Jarvis JP, Peter AP, Keogh M, Baldasare V, Beanland GM, Wilkerson ZT, et al. Real-World Impact of a Pharmacogenomics-Enriched Comprehensive Medication Management Program. J Pers Med. 2022;12(3).
• 17 Truong TM, Apfelbaum JL, Danahey K, Schierer E, Ludwig J, George D, et al. Pilot Findings of Pharmacogenomics in Perioperative Care: Initial Results From the First Phase of the ImPreSS Trial. Anesth Analg. 2022;135(5).
• 18 Nuñez-Medina H, Monero M, Torres LM, Leal E, González-Sepúlveda L, Mayor ÁM, et al. Implementing a Pharmacogenomic-driven Algorithm to Guide Antiplatelet Therapy among Caribbean Hispanics: A non-randomized prospective cohort study. medRxiv. 2023 Dec 6;
• 19 Varughese LA, Bhupathiraju M, Hoffecker G, Terek S, Harr M, Hakonarson H, et al. Implementing Pharmacogenetic Testing in Gastrointestinal Cancers [IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 Screening to Guide Chemotherapy Dosing. Front Oncol. 2022;12.
• 20 Obeng AO, Scott SA, Kaszemacher T, Ellis SB, Mejia A, Gomez A, et al. Prescriber Adoption of SLCO1B1 Genotype-Guided Simvastatin Clinical Decision Support in a Clinical Pharmacogenetics Program. Clin Pharmacol Ther. 2023;113(2).
• 21 Tomcsanyi KM, Tran KA, Bates J, Cunningham FE, Silverman R, Norris AK, et al. Veterans Health Administration: Implementation of pharmacogenomic clinical decision support with statin medications and the SLCO1B1 gene as an exemplar. American Journal of Health-System Pharmacy. 2023;80(16).
• 22 Woosley RL, Simmons J, Sefilyan EM, Atkins S, Black K, Read WA. Linking Technology to Address the Social and Medical Determinants of Health for Safe Medicines Use. J Patient Saf. 2022;18(2).
• 23 Boston D, Larson AE, Sheppler CR, O'Connor PJ, Sperl-Hillen JAM, Hauschildt J, et al. Does Clinical Decision Support Increase Appropriate Medication Prescribing for Cardiovascular Risk Reduction? Journal of the American Board of Family Medicine. 2023;36(5).
• 24 Eadon MT, Cavanaugh KL, Orlando LA, Christian D, Chakraborty H, Steen-Burrell KA, et al. Design and rationale of GUARDD-US: A pragmatic, randomized trial of genetic testing for APOL1 and pharmacogenomic predictors of antihypertensive efficacy in patients with hypertension. Contemp Clin Trials. 2022;119.
• 25 David SP, Dunnenberger HM, Choi S, DePersia A, Ilbawi N, Ward C, et al. Personalized medicine in a community health system: the NorthShore experience. Front Genet. 2023;14:1308738.
• 26 Campbell IM, Karavite DJ, McManus ML, Cusick FC, Junod DC, Sheppard SE, et al. Clinical decision support with a comprehensive in-EHR patient tracking system improves genetic testing follow up. Journal of the American Medical Informatics Association. 2023;30(7).
• 27 Bosserman LD, Mambetsariev I, Ladbury C, Barzi A, Johnson D, Morse D, et al. Pyramidal Decision Support Framework Leverages Subspecialty Expertise across Enterprise to Achieve Superior Cancer Outcomes and Personalized, Precision Care Plans. J Clin Med. 2022;11(22).
• 28 Patel JS, Patel K, Vo H, Jiannan L, Tellez MM, Albandar J, et al. Enhancing an AI-Empowered Periodontal CDSS and Comparing with Traditional Perio-risk Assessment Tools. AMIA Annu Symp Proc. 2022.
• 29 Rousseau JF, Oliveira E, Tierney WM, Khurshid A. Methods for development and application of data standards in an ontology-driven information model for measuring, managing, and computing social determinants of health for individuals, households, and communities evaluated through an example of asthma. J Biomed Inform. 2022;136.
• 30 Lau-Min KS, Bleznuck J, Wollack C, McKenna DB, Long JM, Hubert AP, et al. Development of an Electronic Health Record–Based Clinical Decision Support Tool for Patients With Lynch Syndrome. JCO Clin Cancer Inform. 2023;(7).
• 31 Zorn KK, Simonson ME, Faulkner JL, Carr CL, Acuna J, Hall TL, et al. Can Automated Alerts in the Electronic Health Record Encourage Referrals for Genetic Counseling and Testing Among Patients at High Risk for Hereditary Cancer Syndromes? JCO Oncol Pract. 2022;18(7).
• 32 Jiang S, Mathias PC, Hendrix N, Shirts BH, Tarczy-Hornoch P, Veenstra D, et al. Implementation of pharmacogenomic clinical decision support for health systems: a cost-utility analysis. Pharmacogenomics Journal. 2022;22(3).
• 33 Brixner D, Biltaji E, Bress A, Unni S, Ye X, Mamiya T, et al. The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy. J Med Econ. 2016;19(3).
• 34 Elliott LS, Henderson JC, Neradilek MB, Moyer NA, Ashcraft KC, Thirumaran RK. Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial. PLoS One. 2017;12(2).
• 35 Wiley K, Findley L, Goldrich M, Rakhra-Burris TK, Stevens A, Williams P, et al. A research agenda to support the development and implementation of genomics-based clinical informatics tools and resources. Journal of the American Medical Informatics Association. 2022;29(8).
• 36 Masys DR, Jarvik GP, Abernethy NF, Anderson NR, Papanicolaou GJ, Paltoo DN, et al. Technical desiderata for the integration of genomic data into Electronic Health Records. J Biomed Inform. 2012;45(3).
• 37 Welch BM, Eilbeck K, Fiol G Del, Meyer LJ, Kawamoto K. Technical desiderata for the integration of genomic data with clinical decision support. Vol. 51, Journal of Biomedical Informatics. 2014.
• 38 Williams MS, Taylor CO, Walton NA, Goehringer SR, Aronson S, Freimuth RR, et al. Genomic information for clinicians in the electronic health record: Lessons learned from the clinical genome resource project and the electronic medical records and genomics network. Front Genet. 2019;10(OCT).
• 39 Gill PS, Yu FB, Porter-Gill PA, Boyanton BL, Allen JC, Farrar JE, et al. Implementing pharmacogenomics testing: Single center experience at arkansas children's hospital. J Pers Med. 2021;11(5).
• 40 Qureshi S, Latif A, Condon L, Akyea RK, Kai J, Qureshi N. Understanding the barriers and enablers of pharmacogenomic testing in primary care: A qualitative systematic review with meta-aggregation synthesis. Vol. 23, Pharmacogenomics. 2022.
• 41 van der Wouden CH, Paasman E, Teichert M, Crone MR, Guchelaar HJ, Swen JJ. Assessing the implementation of pharmacogenomic panel-testing in primary care in the Netherlands utilizing a theoretical framework. J Clin Med. 2020;9(3).
• 42 Carter AB, Abruzzo L V., Hirschhorn JW, Jones D, Jordan DC, Nassiri M, et al. Electronic Health Records and Genomics: Perspectives from the Association for Molecular Pathology Electronic Health Record [EHR) Interoperability for Clinical Genomics Data Working Group. Vol. 24, Journal of Molecular Diagnostics. 2022.
• 43 Fahim SM, Alexander CSW, Qian J, Ngorsuraches S, Hohmann NS, Lloyd KB, et al. Current published evidence on barriers and proposed strategies for genetic testing implementation in health care settings: A scoping review. Vol. 63, Journal of the American Pharmacists Association. 2023.
• 44 Caraballo PJ, Sutton JA, Giri J, Wright JA, Nicholson WT, Kullo IJ, et al. Integrating pharmacogenomics into the electronic health record by implementing genomic indicators. Journal of the American Medical Informatics Association. 2020;27(1).
• 45 Xu J, Yang P, Xue S, Sharma B, Sanchez-Martin M, Wang F, et al. Translating cancer genomics into precision medicine with artificial intelligence: applications, challenges and future perspectives. Vol. 138, Human Genetics. 2019.
• 46 Martínez-García M, Hernández-Lemus E. Data Integration Challenges for Machine Learning in Precision Medicine. Vol. 8, Frontiers in Medicine. 2022.
• 47 Weitzel KW, Elsey AR, Langaee TY, Burkley B, Nessl DR, Obeng AO, et al. Clinical pharmacogenetics implementation: Approaches, successes, and challenges. Am J Med Genet C Semin Med Genet. 2014;166(1).
• 48 Landry LG, Ali N, Williams DR, Rehm HL, Bonham VL. Lack of diversity in genomic databases is a barrier to translating precision medicine research into practice. Health Aff. 2018;37(5).
• 49 Hoffman JM, Flynn AJ, Juskewitch JE, Freimuth RR. Biomedical Data Science and Informatics Challenges to Implementing Pharmacogenomics with Electronic Health Records. Vol. 3, Annual Review of Biomedical Data Science. 2020.
• 50 Ayatollahi H, Hosseini SF, Hemmat M. Integrating genetic data into electronic health records: Medical geneticists' perspectives. Healthc Inform Res. 2019;25(4).
• 51 Alarcón Garavito GA, Moniz T, Déom N, Redin F, Pichini A, Vindrola-Padros C. The implementation of large-scale genomic screening or diagnostic programmes: A rapid evidence review. Vol. 31, European Journal of Human Genetics. 2023.
• 52 O'Shea J, Ledwidge M, Gallagher J, Keenan C, Ryan C. Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic review. Vol. 22, Pharmacogenomics Journal. 2022.